We report the predictors of mid-term survival in patients who survive the ICU phase.
The following study compares mid-term survival rates and causes for reoperation between fixed bearing (FB) TKAs.
To determine the effect of pre-operative factors on mid-term survival of patients enrolled in an Australian audit of endovascular aneurysm repair (EVAR).
24 In our report low BMI also predicted reduced mid-term survival after surgery, in accordance with previous longitudinal reports 25 and post-interventional cardiology studies.
According to our data, octogenarians with logistic EuroScore <20% seem to be acceptable candidates for TAVI procedures with good mid-term survival and reasonably low morbidity.
Although numeral clinical studies report short- and mid-term survival of different HRA systems, these studies focus on a limited number of HRA designs.
In the present study, octogenarians with logistic EuroScore <20% could be identified as candidates with good mid-term survival and relatively low morbidity.
We developed prognostic models to examine whether there was an additional effect of social deprivation on all cause in hospital mortality and mid-term survival.
A recent Australian study of 2026 patients with THR and 535 with TKR found no difference in mid-term survival rates between the obese (BMI > 30 kg/m) and non-obese.
Recently, a randomized, double-blind, placebo-controlled trial demonstrated that CQ may improve mid-term survival when given in addition to conventional chemotherapy and radiotherapy for glioblastoma multiforme [26], [27].
4), and thus may be used as an adjuvant for the GBM therapy, this was confirmed by Briceno et al[ 39, 40], who showed that chloroquine may improve mid-term survival when given in addition to conventional therapy for GBM.
